Single-shot dose and continuous infusion of TXA have similar efficacy in primary TKA
Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomised clinical trialArch Orthop Trauma Surg. 2015 Apr;135(4):465-71
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
106 patients undergoing total knee arthroplasty were randomized to receive either a 30mg/kg bolus dose of tranexamic acid (TXA), or 10mg/kg dose TXA plus 2mg/kg/h continuous infusion postoperatively for 20 hours. The purpose of this study was to compare blood loss within the first week of surgery, as well as complications and clinical outcomes within the first year of surgery. The findings illustr...
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.Continue